BioAgilytix

ProteoGenex is an established, innovative provider of biological specimens and clinical information of the highest quality standards.

We are a privately held US company founded in Los Angeles, CA in 2003. With headquarters in Culver City, CA, we also have a large, state-of-the-art research laboratory in Moscow, Russia.

The ProteoGenex team consists of 35 employees, including 30 Molecular Biologists, Cell Biologists, Biochemists, and Pathologists (15 PhDs, 5 MDs, 15 MSs).

Our biorepository offers an extensive inventory of biospecimens as well as an exclusive, custom-design human tissue-based research service, which is the company’s largest and fastest growing business segment.
Our unique and comprehensive biobank is composed of well-defined and categorized clinical samples, including frozen and FFPE tissues, blood, serum, plasma, bone marrow, tissue microarrays, etc. All ProteoGenex specimens are collected from a vast network of academic and professional clinical institutions under strict regulatory and ethical standards.

We have over 200,000 individual biomaterials covering disease targets in the fields of Oncology, Dermatology, Neurology, Immunology, Infectious Diseases, Autoimmune and Metabolic Disorders, and many more. Our products are derived from a variety of diseased human sources as well as from normal tissues. All specimens are supported by extensive pathology information and patient’s’ clinical history documentation.

ClinChoice is a full-service clinical CRO dedicated to offering high-quality, efficient and flexible solutions to pharmaceutical, biotechnology, medical device, and consumer products clients worldwide. With a 25 year history of success, ClinChoice continues to be The Standard of Excellence for biostatistics, clinical operations, data management, statistical programming, CDISC, regulatory affairs, medical affairs and pharmacovigilance. ClinChoice has established major delivery centers across US, China, Europe, India, Japan and the Philippines. It has over 1,800 employees globally, with a strong and talented team, and a growing clinical operations presence in seven countries across Asia, North America and Europe.

A biotechnology company which provides quality life science products, such as, antibodies, reagents, and assays for inflammatory and autoimmune diseases, pain, metabolism, oncology, and neurology research.

Evotec is a life science company with a unique business model that delivers on its mission to discover and develop highly effective therapeutics and make them available to the patients. The Company’s multimodality platform comprises a unique combination of innovative technologies, data and science for the discovery, development, and production of first-in-class and best-in-class pharmaceutical products. Evotec leverages this “Data-driven R&D Autobahn to Cures” for proprietary projects and within a network of partners including all Top 20 Pharma and over 800 biotechnology companies, academic institutions, as well as other healthcare stakeholders. Evotec has strategic activities in a broad range of currently underserved therapeutic areas, including e.g. neurology, oncology, as well as metabolic and infectious diseases. Within these areas of expertise, Evotec aims to create the world-leading co-owned pipeline for innovative therapeutics and has to-date established a portfolio of more than 200 proprietary and co-owned R&D projects from early discovery to clinical development. Evotec operates globally with more than 3,700 highly qualified people. The Company’s 14 sites offer highly synergistic technologies and services and operate as complementary clusters of excellence.

Founded in 2004, Pharmaron is a cutting-edge, fully integrated pharmaceutical R&D service platform supporting the life science industry. The company has invested in its people and facilities and established its comprehensive service offerings throughout the pharmaceutical R&D lifecycle. With operations in China, the US and the UK staffed by more than 11,000 employees, Pharmaron has an excellent track record in delivering end-to-end R&D solutions to its partners globally and enabling them to accelerate their novel drug discovery and development process.

Pharmaron is a contract research organization (CRO).

Services:
* Synthetic, medicinal and analytical chemistry services
* Biology services
* DMPK services
* Pharmacology services
* Drug safety assessment services
* Radiochemistry and isotopically labelled metabolism services
* Chemical & pharmaceutical development services
* Clinical development services

www.pharmaron.com

CRO - Contract Research Organization
Library Synthesis
CADD
Bioorganic Chemistry
Discovery Process Chemistry
Radiolabelled Chemical Synthesis
ChemInformatics
in vitro Biology
in vitro Screening
Structural Biology
in vivo Pharmacology
Animal Disease Models
ex vivo Pharmacology
Biomarkers
in vitro ADME
in vivo PK
PKPD
QA
Regulatory Affairs
Discovery Biologics
Process Chemistry
API Manufacturing
Material Science
Formulation Development
Drug Product Manufacturing
Toxicology
Safety Pharmacology
Genetic Toxicology
DART
Pathology
Immunotoxicity
Bioanalytical
14C / Carbon-14 Radiosynthesis
3H / Tritium Radiosynthesis
QWBA
mARG
Clinical AME
Mass Balance
Metabolite Profiling
Microdosing Phase 0
Absolute Bioavailability
DDI
First-in-Human (FIH)
Thorough QT(TQT)
Ethnobridging